Systemic Inflammation Biomarkers Predict Survival in Patients of Early Stage Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiotherapy - A Single Center Experience

Background: Increasing evidence indicates a relationship between systemic inflammation and survival following treatment in various tumors. However, the correlation of systematic inflammation with survival after stereotactic ablative radiotherapy (SABR) in early stage non-small cell lung cancer (NSCL...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Hui, Ge, Hong, Cui, Yingying, Zhang, Jiangong, Fan, Ruitai, Zheng, Anping, Zheng, Xiaoli, Sun, Yanan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743726/
https://www.ncbi.nlm.nih.gov/pubmed/29290784
http://dx.doi.org/10.7150/jca.21703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743726/
https://www.ncbi.nlm.nih.gov/pubmed/29290784
http://dx.doi.org/10.7150/jca.21703

Ejemplares similares